155 related articles for article (PubMed ID: 8226955)
1. Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast.
Wrenn CK; Katzenellenbogen BS
J Biol Chem; 1993 Nov; 268(32):24089-98. PubMed ID: 8226955
[TBL] [Abstract][Full Text] [Related]
2. Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor. Alterations in binding and transcriptional activation by covalently and reversibly attaching ligands.
Reese JC; Katzenellenbogen BS
J Biol Chem; 1991 Jun; 266(17):10880-7. PubMed ID: 2040605
[TBL] [Abstract][Full Text] [Related]
3. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor.
Pakdel F; Reese JC; Katzenellenbogen BS
Mol Endocrinol; 1993 Nov; 7(11):1408-17. PubMed ID: 8114756
[TBL] [Abstract][Full Text] [Related]
4. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
5. Powerful dominant negative mutants of the human estrogen receptor.
Ince BA; Zhuang Y; Wrenn CK; Shapiro DJ; Katzenellenbogen BS
J Biol Chem; 1993 Jul; 268(19):14026-32. PubMed ID: 8314770
[TBL] [Abstract][Full Text] [Related]
6. Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination.
Pakdel F; Katzenellenbogen BS
J Biol Chem; 1992 Feb; 267(5):3429-37. PubMed ID: 1737796
[TBL] [Abstract][Full Text] [Related]
7. Use of the yeast one-hybrid system to screen for mutations in the ligand-binding domain of the estrogen receptor.
Bush SM; Folta S; Lannigan DA
Steroids; 1996 Mar; 61(3):102-9. PubMed ID: 8852826
[TBL] [Abstract][Full Text] [Related]
8. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
[TBL] [Abstract][Full Text] [Related]
9. Generation of estrogen receptor mutants with altered ligand specificity for use in establishing a regulatable gene expression system.
Whelan J; Miller N
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):3-12. PubMed ID: 8809181
[TBL] [Abstract][Full Text] [Related]
10. Probing the structure and function of the estrogen receptor ligand binding domain by analysis of mutants with altered transactivation characteristics.
Eng FC; Lee HS; Ferrara J; Willson TM; White JH
Mol Cell Biol; 1997 Aug; 17(8):4644-53. PubMed ID: 9234721
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor mutants which do not bind 17 beta-estradiol dimerize and bind to the estrogen response element in vivo.
Zhuang Y; Katzenellenbogen BS; Shapiro DJ
Mol Endocrinol; 1995 Apr; 9(4):457-66. PubMed ID: 7659089
[TBL] [Abstract][Full Text] [Related]
12. Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems.
Katzenellenbogen BS; Bhardwaj B; Fang H; Ince BA; Pakdel F; Reese JC; Schodin D; Wrenn CK
J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):39-48. PubMed ID: 8274440
[TBL] [Abstract][Full Text] [Related]
13. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
[TBL] [Abstract][Full Text] [Related]
14. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer.
Kumar V; Chambon P
Cell; 1988 Oct; 55(1):145-56. PubMed ID: 3167974
[TBL] [Abstract][Full Text] [Related]
15. A highly conserved region in the hormone-binding domain of the human estrogen receptor functions as an efficient transactivation domain in yeast.
Pierrat B; Heery DM; Chambon P; Losson R
Gene; 1994 Jun; 143(2):193-200. PubMed ID: 8206373
[TBL] [Abstract][Full Text] [Related]
16. Agonistic and synergistic activity of tamoxifen in a yeast model system.
Graumann K; Jungbauer A
Biochem Pharmacol; 2000 Jan; 59(2):177-85. PubMed ID: 10810452
[TBL] [Abstract][Full Text] [Related]
17. Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol, and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro.
Klinge CM; Traish AM; Driscoll MD; Hilf R; Bambara RA
Steroids; 1996 May; 61(5):278-89. PubMed ID: 8738832
[TBL] [Abstract][Full Text] [Related]
18. Directed evolution of human estrogen receptor variants with significantly enhanced androgen specificity and affinity.
Chen Z; Katzenellenbogen BS; Katzenellenbogen JA; Zhao H
J Biol Chem; 2004 Aug; 279(32):33855-64. PubMed ID: 15159406
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of the human estrogen receptor using a phenotypic transactivation assay in yeast.
Pierrat B; Heery DM; Lemoine Y; Losson R
Gene; 1992 Oct; 119(2):237-45. PubMed ID: 1398105
[TBL] [Abstract][Full Text] [Related]
20. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
Cho H; Katzenellenbogen BS
Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
